Form D · Pharmaceuticals
OnKure Therapeutics, Inc.
Boulder, CO · CIK 0001637715
Offering snapshot reported Oct 21, 2024 · SEC filing
- Reported sold
- $65M Offering amount: $65M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 4, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 21, 2024 | Initial | $65,000,000 | No comparison | 20 | SEC filing |
| Dec 21, 2020 | Initial | $47,384,999 | No comparison | 15 | SEC filing |
| May 14, 2019 | Initial | $25,000,002 | No comparison | 9 | SEC filing |
| Jan 8, 2018 | Initial | $21,994,682 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $3.25M
- Finders' fees
- $0
- Form D file number
- 021-527340
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Evercore Group, L.L.C | 42405 | |
| Leerlink Partners LLC | 39011 | |
| LifeSci Capital, LLC | 168404 |
Source: Form D, filed Oct 21, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Samuel Agresta | Executive |
| Lon Cardon, Ph.D. | Director |
| R. Michael Carruthers | Director |
| Mike Cruse | Executive |
| Alejandro Dorenbaum, M.D. | Executive |
| Gregory Flesher | Director, Executive |
| Michael G. Grey | Director |
| Kenneth Harrison | Director |
| Dylan Hartley | Executive |
| Valerie M. Jansen | Director |
| Wendy Johnson | Executive |
| Johan Kordel, Ph.D. | Director |
| Jason Leverone | Executive |
| Isaac Manke | Director |
| Edward T. Mathers | Director |
| Ed Mathers | Director |
| Bali Muralidhar | Director |
| Niall O'donnell | Director, Executive |
| Niall O'donnell, Ph.D. | Director |
| Art Pappas | Director |
| Andrew Johm Phillips | Director |
| Nicholas Saccomano | Director, Executive |
| Stacey Seltzer | Director |
| Scott Weiner | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6707 Winchester Circle, Suite 400
Boulder, CO, 80301
Boulder, CO, 80301